Sandostatin LAR for cystoid diabetic macular edema: a 1-year experience

We report the clinical outcome of a 46-year-old diabetic patient with cystoid macular edema treated with Sandostatin ® long-acting release (LAR). Because cystoid changes in both eyes were refractive to conventional treatment (i.e., vitrectomy and periocular steroids), the patient was treated with Sa...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes research and clinical practice 2004-04, Vol.64 (1), p.71-72
Hauptverfasser:	Hernaez-Ortega, Maria Concepcion, Soto-Pedre, Enrique, Martin, Juan Jose Beitia
Format:	Artikel
Sprache:	eng
Schlagworte:	Cystoid macular edema Delayed-Action Preparations Diabetes mellitus Diabetes Mellitus, Type 1 - physiopathology Diabetic retinopathy Diabetic Retinopathy - drug therapy Humans Macular Edema - diagnosis Macular Edema - etiology Male Middle Aged Octreotide - administration & dosage Octreotide - therapeutic use Somatostatin
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!